Ane-Kristine Finbråten is a postdoctoral fellow at the Unger Vetlesen Institute. She focuses on care models for people who inject drugs and co-founded "The Centre for Elimination of Hepatitis in Norway". She was a 2021-22 Harkness Fellow at the Department of Population Health Sciences, Weill Cornell Medicine

Nurse Mim focuses on screening and linking homeless, marginalised and incarcerated people to Hepatitis C care and cure with Kombi Clinic. As well as leading fingerstick point-of-care testing campaigns throughout Queensland Corrections, she gets to wear a fabulous Hawaiian shirt and drives around in a bright yellow Van called Ruby.

Epidemiologist working at the intersection of social justice and infectious diseases.

Dr. Ramers is board-certified in internal medicine, infectious disease, and addition medicine. He served as assistant medical director leading MAT, HIV/HCV, and street medicine at FHCSD, a safety net clinic in San Diego, and was senior clinical advisor with the CHAI Global Hepatitis program. He is now an Executive Director of Global Medical Affairs in Virology at Gilead Sciences.

Evan is a research fellow at the Kirby Institute in Sydney Australia. He is interested in clinical and interventional research to achieve HCV elimination.

Shana is a research associate at the Vancouver Infectious Diseases Centre specializing in HCV and HIV research amongst people who use drugs from the inner-city of Vancouver. She is currently a graduate student at the University of Rochester, New York.

Dr. Myat Kay Khine is Deputy Director of AHRN and one of the technical supervisors who leads the medical intervention of the largest harm reduction organization in Myanmar, and she has more than 7 years of experience in the harm reduction field.

Mercy Nyakowa has provided technical leadership in the design, implementation and dissemination of rigorous research programs bringing evidence-based health interventions to scale since 2011. Her research experience has been particularly centred around direct translation of research into evidence-based policy and practice in HIV&HCV prevention, care and treatment in Kenya.

Dr. Jennifer Havens is a Professor and infectious disease epidemiologist at the Center on Drug and Alcohol Research at the University of Kentucky College of Medicine. She primarily studies HCV and other infectious complications of substance use in rural U.S. populations.